Tubular Injury Biomarkers to Predict Chronic Kidney Disease and Hypertension at 3-Months Post-Cisplatin in Children.

Ryan St Huang Kelly R McMahon Stella Wang Hayton Chui Asaf LebelJasmine LeeVedran CockovskiShahrad Rod RassekhKirk R Schultz Tom David Blydt-Hansen Geoffrey D E CuvelierCherry MammenMaury Pinsk Bruce C CarletonRoss T TsuyukiColin J D Ross Ana Palijan Michael Zappitellinull null

Published in: Kidney360 (2024)

Tubular injury biomarkers we studied were individually not strong predictors of 3-month post-cisplatin kidney outcomes. Adding biomarkers to existing clinical prediction models may help predict post-therapy hypertension and identify higher kidney-risk patients.

Keyphrases

end stage renal disease
chronic kidney disease
blood pressure
peritoneal dialysis
ejection fraction
newly diagnosed
type diabetes
high glucose
mesenchymal stem cells
skeletal muscle
smoking cessation
glycemic control
breast cancer risk